Clinical Journal of Oncology Nursing back issues from February 2007:
Health promotion: whose responsibility is it?(Guest Editorial)(Editorial)
Feb 01, 2007; ... Another new year is upon us. Human nature encourages people to strive to do better. Consequently, each new year, millions of people resolve to make changes in their lives. This year I will ... stop smoking, eat better, walk more, get a mammogram, reduce stress, be a better parent, keep the ...
Correction.(Correction notice)
Feb 01, 2007 ... In Continuing Education Test 2 of the December 2006 issue (Vol. 10, No. 6, pp. 816-818), question 5 reads, "A patient who received an allogeneic peripheral blood stem cell transplantation 80 days ago reports to the clinic with complaints of increasing fatigue and is noted to have a mild ...
Lymphedema and implications for oncology nursing practice.(Oncology Nursing 101)
Feb 01, 2007; ... Lymphedema (LE) is described as chronic swelling caused by impairment in lymphatic system drainage. The cause of LE is either primary or secondary (Holcomb, 2006). The experience can be disturbing. Patients and healthcare providers often overlook the initial presentation because of subtle ...
Priapism in the oncology setting.(Case Analysis)
Feb 01, 2007; ... Case Study: N.L. is a 20-year-old Caucasian man with no significant medical history. He presented to the hospital with a two-day history of feeling ill with intermittent nausea, vomiting, blurred vision, and headache. He also noted slurred speech and left-upper-quadrant fullness for almost ...
Diagnosing fungal infections in neutropenic patients.(Diagnostic Reasoning)
Feb 01, 2007; ... Fungal infections are among the most serious complications in neutropenic patients. A major problem that has compromised management of fungal infections is healthcare professionals' inability to recognize the infections when they occur. No adequate diagnostic tools exist to detect many of ...
Seizures in people with cancer.(Diagnostic Reasoning)
Feb 01, 2007; ... Case Study: Ms. S is a 52-year-old woman who was diagnosed with infiltrating ductal breast carcinoma two years prior. She was treated with mastectomy followed by focal radiation and FAC (5-fluorouracil, adriamycin, and cyclophosphamide). One year ago, she began experiencing headaches. A ...
Interventions for the management of weight and body composition changes in women with breast cancer.(CJON WRITING MENTORSHIP PROGRAM ARTICLE)
Feb 01, 2007; ... Weight gain and body composition changes are common during the first year after breast cancer diagnosis. Women who are overweight or obese at the time of diagnosis or who gain weight following diagnosis are at higher risk for adverse clinical outcomes. Unhealthy weight conditions, ...
Hematopoietic stem cell transplantation: implications for critical care nurses.(CJON WRITING MENTORSHIP PROGRAM ARTICLE)
Feb 01, 2007; ... Hematopoietic stem cell transplantation (HSCT) is being used increasingly in the treatment of malignant and onmalignant diseases. The treatment modality has been proven effective but is not without risks. Studies consistently have identified the need for advanced supportive care (e.g., ...
Putting evidence into practice: evidence-based interventions to prevent, manage, and treat chemotherapy-induced nausea and vomiting.
Feb 01, 2007; ... Chemotherapy-induced nausea and vomiting (CINV) continues to have a considerable effect on the physical and psychological well-being of patients with cancer, despite significant advances in antiemetic drugs since the 1990s. This article reviews and summarizes past and current empirical ...
Modeling a better way: navigating the healthcare system for patients with lung cancer.(CJON WRITING MENTORSHIP PROGRAM ARTICLE)
Feb 01, 2007; ... The coordination of services for patients with suspected or newly diagnosed lung cancer produces improved patient outcomes, particularly in their quality of life. Evidence-based practice demonstrates mproved outcomes from the multimodality therapies offered today, especially for patients ...
Recognizing hyperviscosity syndrome in patients with Waldenstrom macroglobulinemia.
Feb 01, 2007; ... Hyperviscosity syndrome can develop in patients with plasma cell dyscrasias, particularly Waldenstrom macroglobulinemia (WM). Occurring in 10%-30% of patients with hyperviscosity syndrome, WM is an uncommon B-cell proliferative disorder characterized by bone marrow infiltration and ...
Putting evidence into practice: evidence-based interventions for fatigue during and following cancer and its treatment.
Feb 01, 2007; ... Cancer-related fatigue has a significant impact on patients' physical and psychosocial functioning, symptom distress, and quality of life, yet it remains under-recognized and undertreated. The Oncology Nursing Society's Putting Evidence Into Practice initiative sought to improve patient ...
Obtaining family histories from patients with cancer.
Feb 01, 2007; ... Information obtained from family history data can provide valuable insight into the biologic and environmental etiologies of an individual's personal and family history of disease. The purpose of this article is to provide a brief introduction to cancer genetics and discuss ways to obtain ...
Overview of second-generation tyrosine kinase inhibitors for patients with imatinib-resistant chronic myelogenous leukemia.
Feb 01, 2007; ... Imatinib mesylate (Gleevec[R], Novartis Pharmaceuticals Corporation, East Hanover, NJ) has revolutionized the treatment of chronic myelogenous leukemia (CML) with marked improvement in survival in all three phases--chronic, accelerated, and blast. Most patients with CML now receive ...
Continuing nursing education.
Feb 01, 2007 ... Goal: The goal of this continuing nursing education program is to further enhance the nurse's knowledge of the topic areas discussed in the articles. Accreditation: The Oncology Nursing Society is accredited as a provider of continuing education in nursing by the American Nurses ...
Hematologic effects.(CJON BOOK EXCERPT SERIES)(Excerpt)
Feb 01, 2007; ... This excerpt, chapter 7 from the book Hematopoietic Stem Cell Transplantation: A Manual for Nursing Practice, edited by Susan A. Ezzone, MS, RN, CNP, is part of a series of clinically relevant reprints that appear regularly in the Clinical Journal of Oncology Nursing. The most ...
Conference calendar.(Calendar)
Feb 01, 2007 ... Southeast Third Annual Perspectives in Oncology Practice. March 10. Location: Hard Rock Hotel and Casino, Hollywood, FL. Sponsor: Miami Cancer Center at Mercy Hospital. Fee: $60 for Oncology Nursing Society members; $65 for nonmembers. Contact hours: 6.5 continuing education ...
Cytokine-release syndrome: overview and nursing implications.
Feb 01, 2007; ... Cytokine-release syndrome is a symptom complex associated with the use of many monoclonal antibodies. Commonly referred to as an infusion reaction, it results from the release of cytokines from cells targeted by the antibody as well as immune effector cells recruited to the area. When ...
Emerging therapeutic options for B-cell disorders: idiopathic thrombocytopenic purpura and chronic lymphocytic leukemia.
Feb 01, 2007; ... B-cell disorders include a large group of malignant and nonmalignant diseases with tremendous variation in incidence, natural history, treatment, and prognosis. This article will focus on adult idiopathic thrombocytopenic purpura (ITP) and chronic lymphocytic leukemia (CLL). Clinicians ...
Treatment approaches and nursing applications for non-Hodgkin lymphoma.(Report)
Feb 01, 2007; ... Non-Hodgkin lymphoma (NHL), a malignancy that manifests in the lymphatic system, is one of the most commonly occurring hematologic disease types in the United States and other Westernized countries. NHL is divided into a range of subtypes with differing clinical features and outcomes ....
Introduction to B-cell disorders.
Feb 01, 2007; ... Healthcare professionals have a good understanding of B cells in normal immunity. Although the role of lymphocytes and the lymphoid system in lymphoma is understood, the role of B cells is less clear in several autoimmune diseases, such as rheumatoid arthritis, idiopathic thrombocytopenic ...
Continuing nursing education.
Feb 01, 2007 ... Goal: The goal of this continuing nursing education program is to further enhance the nurse's knowledge of the topic areas discussed in the articles. Accreditation: The Oncology Nursing Society is accredited as a provider of continuing education in nursing by the American Nurses ...